347 related articles for article (PubMed ID: 30015639)
1. New biologics in the treatment of urticaria.
Kocatürk E; Zuberbier T
Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):425-431. PubMed ID: 30015639
[TBL] [Abstract][Full Text] [Related]
2. Biologics for the Use in Chronic Spontaneous Urticaria: When and Which.
Maurer M; Khan DA; Elieh Ali Komi D; Kaplan AP
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1067-1078. PubMed ID: 33685605
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
Kaplan AP; Giménez-Arnau AM; Saini SS
Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.
Altman K; Chang C
Clin Rev Allergy Immunol; 2013 Aug; 45(1):47-62. PubMed ID: 22674016
[TBL] [Abstract][Full Text] [Related]
5. Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent Progress.
Giménez-Arnau AM; Salman A
Drugs; 2020 Nov; 80(16):1617-1634. PubMed ID: 32857360
[TBL] [Abstract][Full Text] [Related]
6. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
Metz M; Ohanyan T; Church MK; Maurer M
J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic autoimmune urticaria with omalizumab.
Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
[TBL] [Abstract][Full Text] [Related]
9. New treatments for chronic urticaria.
Kolkhir P; Altrichter S; Munoz M; Hawro T; Maurer M
Ann Allergy Asthma Immunol; 2020 Jan; 124(1):2-12. PubMed ID: 31446134
[TBL] [Abstract][Full Text] [Related]
10. Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies.
Orzan OA; Popa LG; Mihai MM; Cojocaru A; Giurcăneanu C; Dorobanțu AM
Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744079
[TBL] [Abstract][Full Text] [Related]
11. Omalizumab in children.
Licari A; Marseglia A; Caimmi S; Castagnoli R; Foiadelli T; Barberi S; Marseglia GL
Paediatr Drugs; 2014 Dec; 16(6):491-502. PubMed ID: 25404353
[TBL] [Abstract][Full Text] [Related]
12. The Expanding Field of Biologics in the Management of Chronic Urticaria.
Joshi S; Khan DA
J Allergy Clin Immunol Pract; 2017; 5(6):1489-1499. PubMed ID: 28734860
[TBL] [Abstract][Full Text] [Related]
13. Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease.
Martina E; Diotallevi F; Bianchelli T; Paolinelli M; Offidani A
Curr Pharm Biotechnol; 2021; 22(1):32-45. PubMed ID: 32603278
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab for the treatment of chronic urticaria.
Zuberbier T; Maurer M
Expert Rev Clin Immunol; 2015 Feb; 11(2):171-80. PubMed ID: 25566680
[TBL] [Abstract][Full Text] [Related]
15. Biologics for chronic spontaneous urticaria: toward a personalized treatment.
Asero R; Ferrucci S; Tedeschi A; Cugno M
Expert Rev Clin Immunol; 2022 Dec; 18(12):1297-1305. PubMed ID: 36264653
[TBL] [Abstract][Full Text] [Related]
16. Biologics in Chronic Urticaria.
Bulkhi A; Cooke AJ; Casale TB
Immunol Allergy Clin North Am; 2017 Feb; 37(1):95-112. PubMed ID: 27886913
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab may not inhibit mast cell and basophil activation in vitro.
Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
[TBL] [Abstract][Full Text] [Related]
18. Urticaria and Angioedema: an Update on Classification and Pathogenesis.
Radonjic-Hoesli S; Hofmeier KS; Micaletto S; Schmid-Grendelmeier P; Bircher A; Simon D
Clin Rev Allergy Immunol; 2018 Feb; 54(1):88-101. PubMed ID: 28748365
[TBL] [Abstract][Full Text] [Related]
19. Emerging treatments for chronic urticaria.
Wedi B
Expert Opin Investig Drugs; 2022 Mar; 31(3):281-290. PubMed ID: 35166638
[TBL] [Abstract][Full Text] [Related]
20. Immunological effects of omalizumab in chronic urticaria: a case report.
Iemoli E; Piconi S; Fusi A; Borgonovo L; Borelli M; Trabattoni D
J Investig Allergol Clin Immunol; 2010; 20(3):252-4. PubMed ID: 20635791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
